
	October 28, 2008

Now Available:
Watch podcasts of the Expert Rheumatology Exchange video series

CME Meetings:

Musculoskeletal Report provides cutting-edge scientific updates through biweekly and special edition newsletters, in-depth interviews, and on-location coverage of medical meetings.

With an editorial board of internationally recognized thought leaders, MSK Report is positioned to provide unparalleled quality news reporting with the highest level of credibility.

ACR 2008: Visit MSK Report's dedicated ACR 2008 page
for complete coverage of the American College of Rheumatology's Annual Scientific Meeting, including press conference videos and interviews with presenters.

ACR 2008: Syk Kinase Inhibitor R788 (Tamatinib fosdium) Achieves ACR20 Response Rates Over 60% in Phase II Trial
The oral Syk kinase inhibitor R788 achieved impressive efficacy in a phase II RA trial...

ACR 2008: Tai Chi Rx for Knee OA
Tai chi may help treat pain and physical impairment among patients with severe knee osteoarthritis...

ACR 2008: Pain, Rheumatology Experts Say Stopping Smoking May Cut RA Pain, Disease Activity
Researchers at two major medical meetings are highlighting the role smoking plays in chronic pain and disease activity in RA...

Arthritis: JAMA Biologicals Safety Data Show Impact of What Supreme Court Will Decide in Wyeth v Levine
Nearly one-quarter of biological drugs wind up with additional health warnings within a few years of reaching the market. Experts say this illustrates the importance of a coming US Supreme Court decision on whether FDA approval shields companies from liability for harm caused by approved agents and devices...

BioPharm Business: VGX Initiates Follow-On, Phase I, Multiple Ascending Dose Study for Oral Anti-Inflammatory Drug Targeting RA and Type 1 Diabetes
VGX Pharmaceuticals announced phase I study results that demonstrated that its lead anti-inflammatory compound, VGX-1027, was generally safe and well tolerated in humans...